Navigation Links
Lucintel Report Outlines $100 Billion Market for Global Oncology Drugs Industry in 2018
Date:4/15/2013

Irving, Texas (PRWEB) April 15, 2013

The global oncology drugs industry experienced significant growth during the past five years and is expected to continue that momentum to reach an estimated $100.6 billion in 2018.

Lucintel, a leading global management consulting and market research firm, has analyzed the global oncology drugs industry and presents its findings in “Global Oncology Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis.” The industry comprises firms primarily engaged in the development, manufacture, and marketing of oncology drugs.

Lucintel’s study of the oncology drugs industry includes all classes of drugs that are used as anti-cancer drug for the treatment of lung cancer, mouth cancer, colorectal cancer, skin cancer, kidney cancer, and all such other types of cancer, which are marketed and distributed as oncology drugs.

North America dominates this industry with more than one-third of the market share. Roche Holding Ltd., Novartis AG, Astra Zeneca Plc, Eli Lilly & Co., and Sanofi SA are the major industry players. A combination of factors such as technology innovations, medical insurance coverage, aging population, and changing lifestyles are seen to affect market dynamics significantly. The industry has seen a number of recent changes including growing competition, rise in merger and acquisition activities, increased cancer health insurance coverage, and an increasing amount of foreign direct investment.

As per the study, aging population, changing lifestyles, more effective diagnosing, unhealthy eating habits, and an increasing incidence of chronic diseases across the entire global population will provide growth opportunities for the oncology drugs industry players.

This industry research report provides an overview of the global oncology drugs industry and tracks industry performance in four geographic regions. The report studies manufacturers and distributors of oncology drugs, providing a five-year annual trend analysis that highlights market size, profit and cost structure for North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). The report also provides a forecast, addressing market opportunities for next five years for each of these regions.

For a detailed table of contents and pricing information on this timely, insightful report, contact Lucintel at +1-972-636-5056 or via email at helpdesk(at)lucintel(dot)com. Lucintel provides cutting-edge decision support services that facilitate critical decisions with greater speed, insight, growth consulting and cost efficiency. To learn more, visit http://www.lucintel.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10627682.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lucintel Estimates Global Home Healthcare Device Industry Reach US $29 Billion in 2017
2. Rescheduling of First NuvaRing Lawsuit Trials in State, Federal NuvaRing Lawsuit Litigation, Reports Wright & Schulte LLC
3. EmploymentCrossing.com Backs Latest JOLTS Report of Increasing Job Openings Across America
4. Big Data Analytics (Hadoop-as-a-Service) Market is growing at 54.9%. CAGR to reach $13.95 Billion by 2017 - New Report by MarketsandMarkets
5. 2013 Top Rated Home Security System Providers in California Reported by SecurityPlanet.com
6. Strides Made in Preventing Cancer, But Challenges Remain: Report
7. Teens Death From Chickenpox Highlights Need for Vaccination, CDC Reports
8. Study reports adenoma detection rates are higher than current guidelines suggest in both men and women
9. Insurance Company Report Confirms Distracted Driver Concerns
10. Report finds continuing challenges in changing behaviors that increase cancer risk
11. Antibiotic Prescribing Rates Vary by Region: Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease ... hospitals in the United States, it’s a threat that is constantly changing and ... infection prevention and offers strategies for the healthcare community to help decrease the ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by ... it does not obey the rules Congress has directed the CBO to follow. The ... GOP reform would restore. Yet, it estimates a reduction in employer-based coverage due to ...
(Date:3/24/2017)... MI (PRWEB) , ... March 24, 2017 , ... ... assistance, financial planning, and related services to families and business owners across eastern ... aimed at feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH ...
(Date:3/24/2017)... ... 2017 , ... As the standards bearer of advanced cancer ... positions them as the go-to thought leader in all matters concerning oncology nursing. ... always-on, always-fresh news, views and advocacy engine, called ONS Voice. , The ONS ...
(Date:3/24/2017)... , ... March 24, 2017 , ... The law firm ... Plains, N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the ... for the firm, will concentrate her practice in elder law, Medicaid planning and applications, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... 2035" report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, ... growing market of deep learning solutions within the healthcare domain. Primarily ... as a novel solution to generate relevant insights from medical data. ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Latin America ... the period 2015 through 2022. Also, a six-year historic analysis is provided ...
(Date:3/24/2017)... BOTHELL, Wash. , March 23, 2017 /PRNewswire/ ... developer of advanced medical technology for non-invasive surgery, ... the Mirabilis System for treatment of uterine fibroids ... that it had received approval from the US ... study of the Mirabilis System in the United ...
Breaking Medicine Technology: